The global pet diabetes care devices market is experiencing significant growth, fueled by an increasing demand for advanced healthcare solutions for pets. Valued at USD 2.3 billion in 2023, the market is projected to nearly double, reaching USD 4.3 billion by 2033, with a robust Compound Annual Growth Rate (CAGR) of 6.2% throughout the forecast period.
Veterinary clinics are playing a crucial role in this expansion, acting as key facilitators in the adoption of pet diabetes care devices. Healthcare professionals and animal caretakers within these clinics are increasingly recommending and utilizing these advanced tools to enhance the management of pet health. These devices are critical for detecting, monitoring, and managing common health issues in pets, helping to prevent complications and ensuring better overall care.
The rising awareness among pet owners, combined with the proactive approach of veterinary clinics, is significantly boosting the adoption of diabetes care devices. By integrating these tools into routine care, pet owners can effectively manage their pets’ health, leading to an improved quality of life for their beloved companions.
Among the various pet diabetes care devices available, insulin pens, glucose monitoring systems, and glucose meters are designed in a range of sizes and shapes, featuring advanced functionalities for ease of use. Veterinary clinics play an instrumental role not only in informing pet owners about their pets’ conditions but also in guiding them on the benefits and usage of these devices. Additionally, they educate pet owners on the importance of providing nutritious food and regularly monitoring blood glucose levels.
With the number of pets diagnosed with diabetes on the rise, the demand for pet diabetes care devices is surging. Veterinary clinics are essential in expanding the market by offering effective tools to support pets’ health conditions, providing comprehensive training on the use of these devices, and ensuring regular monitoring at home.
As the global pet diabetes care devices market continues to grow, veterinary clinics remain at the forefront of advancing pet health management solutions, empowering pet owners to take charge of their pets’ well-being.
Key Takeaways:
- The pet diabetes care devices market is registering a CAGR of 6.2% with a valuation of USD 4.3 billion by 2033.
- In the historical period, the market captured a CAGR of 5.7%, with a valuation of USD 1.7 billion in 2018.
- The United States is a prominent leader in the global market, registering a share of 27% during the forecast period.
- China is one of the significant countries in the Asia Pacific that securing a CAGR of 8.20% by 2033.
- During the forecast period, India is registering a CAGR of 7.50% in the global market.
Increased Market Insight Demand: Get Thorough Analysis and Trends in Our Complete Report!
How Key Players are Focus on Adding Values in the Global Market?
Key players are focusing on innovating pet diabetes care devices by adding advanced features resulting in accuracy, convenience, and ease to use. The key players are deploying small sensors in these devices to monitor pets’ health conditions, such as blood glucose levels. These devices work on a real-time basis as pet owners track the condition of their pets and provide them with healthy nutrition with a proper dietary plan.
The key players developing specially design insulin syringes to provide more accurate information than other devices. These devices provide quick results, increasing the adoption of pet healthcare to treat pets’ poor health conditions. Conversely, guiding pet owners, growing awareness, and innovating easy-to-access pet care devices improve pet health.
Recent Developments in the Global Pet Diabetes Care Devices Market are:
- In September 2021, Zoetis Inc launched its new product VETSCAN IMAGYST. This device offers to monitor pets’ diabetes and health conditions.
- In July 2021, Merck Animal Health launched Vetsulin to manage pets’ diabetes.
- In 2020, IDEXX Laboratories announced its new product device IDEXX SDMA Test to identify kidney disease in cats and dogs and also the complication of diabetes.
- In 2019, Vetoquinol announced its acquisition with Epitopix to provide vaccination for diabetes-diagnosed pets.
Other Essential Players in the Global Market are:
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A.
Pet Diabetes Care Devices Market by Category:
By Animal Type:
- Cats
- Dogs
- Horses
By Device:
- Insulin Delivery Devices
- Insulin Delivery Pen
- Insulin Syringes
- Glucose Monitoring Devices
By End User:
- Veterinary Clinics
- Home Care Settings
- Veterinary Hospitals
Region:
- North America
- Europe
- Latin America
- Asia Pacific
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube